CMXHF News and Press, Csl Ltd From 03/23/22

CSL's (OTCPK:CSLLY) unit CSL Behring reported provisional results of its tender offer to acquire all publicly held shares of Vifor Pharma (OTCPK:GNHAY) for $179.25/ share in a deal valued at ~$11.7B. CSL's participation at the end of the additional acceptance period on March 22 was a total of...

CSL Limited (CSLLY) Q2 2022 Earnings Conference Call February 15, 2022, 19:00 ET Company Participants Paul Perreault - MD, CEO & Executive Director Joy Linton - CFO Mark Dehring - Head, IR Conference Call Participants Lyanne Harrison - Bank of America Merrill Lynch David Low - JPMorgan Ch...

Seqirus, a unit of CSL Limited (OTCPK:CMXHF) (OTCPK:CSLLY), announced the supplemental approval granted by the FDA for a multi-dose vial (MDV) presentation of the influenza vaccine AUDENZ for those aged six years and older. According to the company, the monovalent vaccine, AUDENZ, is the firs...

The following slide deck was published by CSL Limited in conjunction with their 2021 Q4 earnings call. For further details see: CSL Limited 2021 Q4 - Results - Earnings Call Presentation

CSL Limited (CSLLY) Q4 2021 Earnings Conference Call August 17, 2021, 8:00 PM ET Company Participants Mark Dehring - Vice President, Investor Relations Paul Perreault - Chief Executive Officer Joy Linton - Chief Financial Officer Conference Call Participants Lyanne Harrison - Bank of America ...

CSL Limited (CSLLY) Q2 2021 Earnings Conference Call February 17, 2021 6:00 PM ET Company Participants Mark Dehring - Vice President, Investor Relations Paul Perreault - Chief Executive Officer John Levy - Interim Chief Financial Officer Conference Call Participants Lyanne Harrison - Bank of ...

The following slide deck was published by CSL Limited in conjunction with their 2021 Q2 earnings call. For further details see: CSL Limited 2021 Q2 - Results - Earnings Call Presentation

When the market is in a phase of rich valuation, it is tempting to broadly identify the market or these stocks as “overvalued”. Making the distinction between stocks deserving high valuations and those that are overvalued is key, particularly in the current market. T...

Pharming Group N.V. has filed to offer an estimated $10.9 million in Registered Holder shares in a U.S. offering. The firm is commercializing a treatment for hereditary angioedema and developing a treatment for pneumonia brought on by the Covid-19 virus. The firm is generating rev...

Investment Thesis CSL Limited ( CSLLY ) has yet to fully recover from the plasma shortages experienced during the lockdowns. The impact on production is likely to materialize just as elective surgeries resume. The influenza vaccine sales can pick up the slack as fears mount over a flu outb...